Ocala India Association
Displaying 2 - 2 of 3

The Food and Drug Administration cleared the first coronavirus vaccine for emergency use in children as young as 12 on Monday, expanding access to the Pfizer-BioNTech shot to adolescents ahead of the next school year and marking another milestone in the nation’s battle with the virus.

a hand holding an object: The Pfizer-BioNTech coronavirus vaccine, already authorized for adolescents 16 and older, was the first to be tested in younger adolescents. (Carlos Osorio/Reuters)© Carlos Osorio/Reuters The Pfizer-BioNTech coronavirus vaccine, already authorized for adolescents 16 and older, was the first to be tested in younger adolescents. (Carlos Osorio/Reuters)

The decision that the two-shot regimen is safe and effective for younger adolescents had been highly anticipated by many parents and pediatricians, particularly with the growing gap between what vaccinated and unvaccinated people may do safely. Evidence suggests that schools can function at low risk with prevention measures, such as masks and social distancing. But vaccines are poised to increase confidence in resuming in-person activities and are regarded as pivotal to returning to normalcy.

"Adolescents, especially, have suffered tremendously from the covid pandemic. Even though they’re less likely than adults to be hospitalized or have severe illness, their lives really have been curtailed in many parts of the country,” said Kawsar R. Talaat, an assistant professor of international health at the Johns Hopkins Bloomberg School of Public Health. "A vaccine gives them an extra layer of protection and allows them to go back to being kids.”